Delivery Order SPE2DB20D3101-SPE2DB24FRWD7
Award Date
9/24/24
Potential Completion Date
9/25/24
Potential Value
$6.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,029.72 firm fixed-price delivery order is for the supply of INSULIN LISPRO 100 UNIT/ML PEN 3ML, with a completion date of December 21, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB20D1004|SPE2DB25FNGKY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,403.58 firm fixed-price delivery order is for the supply of 4567956734 INSULIN LISPRO 100 UNIT/ML PEN 3ML, with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of INSULIN LISPRO 100 UNIT/ML PEN 3ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 26, 2025 with a completion date of February 27, 2025. The contract has a ceiling value of $1,199.02 and is a firm fixed-price delivery order. The award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds...
This federal contract award is for the delivery of INSULIN LISPRO 100 UNIT/ML VL 10ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,003.77 firm fixed-price delivery order contract has an ultimate completion date of December 16, 2024. It is not designated as a set-aside contract. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, with ID SPE2DB20D1004|SPE2DB25FNFBM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,475.82 firm fixed-price delivery order is for the supply of INSULIN LISPRO 100 UNIT/ML VL 10ML medical products. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,501.12 firm fixed-price delivery order is for the supply of 4565927956 - INSULIN LISPRO 100 UNIT/ML PEN 3ML, with a final completion date of September 25, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a diabetes medication. The contract has a firm fixed price of $1,190.81 and an ultimate completion date of May 30, 2025. This award is not associated with a set-aside program and is open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,343.00 Firm Fixed Price Delivery Order is for the supply of 4565826728 units of Insulin Lispro 100 Unit/mL Pen 3mL, with a completion date of September 17, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,786.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4563284246 units of Insulin Lispro 100 Unit/mL Vial 10mL. The contract has a firm fixed price and an ultimate completion date of January 10, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within...
This federal contract award, with a ceiling value of $1,312.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor to the U.S. government. The contract is for the delivery of Insulin Lispro 100 Unit/mL Pen, a critical medication, to support military treatment facilities and other government healthcare programs. This is a Firm Fixed Price delivery order contract with an ultimate completion date of August...